Logo image of MCHX

MARCHEX INC-CLASS B (MCHX) Stock Fundamental Analysis

NASDAQ:MCHX - Nasdaq - US56624R1086 - Common Stock - Currency: USD

2.13  +0.01 (+0.47%)

Fundamental Rating

3

Overall MCHX gets a fundamental rating of 3 out of 10. We evaluated MCHX against 97 industry peers in the Media industry. No worries on liquidiy or solvency for MCHX as it has an excellent financial health rating, but there are worries on the profitability. MCHX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MCHX has reported negative net income.
In the past year MCHX has reported a negative cash flow from operations.
MCHX had negative earnings in each of the past 5 years.
MCHX had a negative operating cash flow in each of the past 5 years.
MCHX Yearly Net Income VS EBIT VS OCF VS FCFMCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -13.48%, MCHX is not doing good in the industry: 74.23% of the companies in the same industry are doing better.
MCHX has a Return On Equity of -17.46%. This is in the lower half of the industry: MCHX underperforms 60.82% of its industry peers.
Industry RankSector Rank
ROA -13.48%
ROE -17.46%
ROIC N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
MCHX Yearly ROA, ROE, ROICMCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

MCHX has a better Gross Margin (64.66%) than 77.32% of its industry peers.
In the last couple of years the Gross Margin of MCHX has remained more or less at the same level.
MCHX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
MCHX Yearly Profit, Operating, Gross MarginsMCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

MCHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MCHX has more shares outstanding
MCHX has less shares outstanding than it did 5 years ago.
MCHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MCHX Yearly Shares OutstandingMCHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MCHX Yearly Total Debt VS Total AssetsMCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -4.12, we must say that MCHX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MCHX (-4.12) is worse than 79.38% of its industry peers.
There is no outstanding debt for MCHX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.12
ROIC/WACCN/A
WACC9.07%
MCHX Yearly LT Debt VS Equity VS FCFMCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MCHX has a Current Ratio of 2.50. This indicates that MCHX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.50, MCHX belongs to the top of the industry, outperforming 84.54% of the companies in the same industry.
A Quick Ratio of 2.50 indicates that MCHX has no problem at all paying its short term obligations.
MCHX has a Quick ratio of 2.50. This is amongst the best in the industry. MCHX outperforms 84.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
MCHX Yearly Current Assets VS Current LiabilitesMCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MCHX have decreased strongly by -66.67% in the last year.
Looking at the last year, MCHX shows a decrease in Revenue. The Revenue has decreased by -2.67% in the last year.
MCHX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.46% yearly.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-1.48%

3.2 Future

MCHX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.10% yearly.
The Revenue is expected to grow by 1.22% on average over the next years.
EPS Next Y23.5%
EPS Next 2Y32.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.47%
Revenue Next 2Y1.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCHX Yearly Revenue VS EstimatesMCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MCHX Yearly EPS VS EstimatesMCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MCHX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MCHX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCHX Price Earnings VS Forward Price EarningsMCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCHX Per share dataMCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

MCHX's earnings are expected to grow with 32.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCHX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARCHEX INC-CLASS B

NASDAQ:MCHX (7/3/2025, 7:47:07 PM)

2.13

+0.01 (+0.47%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06
Inst Owners62.83%
Inst Owner Change1.79%
Ins Owners8.5%
Ins Owner Change0%
Market Cap93.51M
Analysts82.86
Price Target4.08 (91.55%)
Short Float %0.05%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.57%
Min EPS beat(2)-96.08%
Max EPS beat(2)-47.06%
EPS beat(4)0
Avg EPS beat(4)-67.48%
Min EPS beat(4)-96.08%
Max EPS beat(4)-30.72%
EPS beat(8)4
Avg EPS beat(8)-6.21%
EPS beat(12)6
Avg EPS beat(12)-16.73%
EPS beat(16)10
Avg EPS beat(16)4.05%
Revenue beat(2)0
Avg Revenue beat(2)-4.45%
Min Revenue beat(2)-6.22%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.41%
Min Revenue beat(4)-6.22%
Max Revenue beat(4)-2.27%
Revenue beat(8)0
Avg Revenue beat(8)-3.36%
Revenue beat(12)0
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-2.57%
PT rev (1m)0%
PT rev (3m)60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-50%
EPS NY rev (3m)-71.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.11%
Revenue NY rev (1m)-1.03%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B 2.98
P/tB 6.77
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS1.09
BVpS0.71
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.48%
ROE -17.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.66%
FCFM N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
F-Score6
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.45%
Cap/Sales 1.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z -4.12
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)40.99%
Cap/Depr(5y)32.87%
Cap/Sales(3y)3.05%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y23.5%
EPS Next 2Y32.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-1.48%
Revenue Next Year3.47%
Revenue Next 2Y1.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.27%
OCF growth 3YN/A
OCF growth 5YN/A